OBJECTIVES: To determine the molecular basis for autosomal dominant intermediate hereditary motor and sensory neuropathy (HMSN) in a four generation family. The gene defects in families with intermediate HMSN are not known, but it has been suggested that most have X linked HMSN. METHODS: All participating family members were examined clinically. Genomic DNA was obtained from 10 affected and seven unaffected members. Linkage analysis for the known HMSN loci was first performed. Mutations in the peripheral myelin protein zero gene (PMP0) were sought in two affected members, using one unaffected member for comparison, by amplification of the six exons of the gene followed by single strand conformation polymorphism (SSCP) analysis, dideoxy fingerprinting (ddF), and sequencing. Subsequently, the mutation was screened for in all affected and unaffected members in the family using Alu I digestion and in 100 unrelated control subjects using "snap back" SSCP analysis. Sequencing of cDNA from a sural nerve biopsy from an affected member was also performed. RESULTS: The clinical phenotype was of variable severity, with motor nerve conduction velocities in the intermediate range. Linkage to PMP0 was demonstrated. Analysis of genomic DNA and cDNA for PMP0 identified a novel codon 35 GAC to TAC mutation. The mutation produces an inferred amino acid change of aspartate to tyrosine at codon six of the processed protein (Asp6Tyr) in the extracellular domain and was present in all affected family members but not in 100 unrelated controls. CONCLUSIONS: The present findings further extend the range of phenotypes associated with PMP0 mutations and indicate that families with "intermediate" HMSN need not necessarily be X-linked as previously suggested.
OBJECTIVES: To determine the molecular basis for autosomal dominant intermediate hereditary motor and sensory neuropathy (HMSN) in a four generation family. The gene defects in families with intermediate HMSN are not known, but it has been suggested that most have X linked HMSN. METHODS: All participating family members were examined clinically. Genomic DNA was obtained from 10 affected and seven unaffected members. Linkage analysis for the known HMSN loci was first performed. Mutations in the peripheral myelin protein zero gene (PMP0) were sought in two affected members, using one unaffected member for comparison, by amplification of the six exons of the gene followed by single strand conformation polymorphism (SSCP) analysis, dideoxy fingerprinting (ddF), and sequencing. Subsequently, the mutation was screened for in all affected and unaffected members in the family using Alu I digestion and in 100 unrelated control subjects using "snap back" SSCP analysis. Sequencing of cDNA from a sural nerve biopsy from an affected member was also performed. RESULTS: The clinical phenotype was of variable severity, with motor nerve conduction velocities in the intermediate range. Linkage to PMP0 was demonstrated. Analysis of genomic DNA and cDNA for PMP0 identified a novel codon 35 GAC to TAC mutation. The mutation produces an inferred amino acid change of aspartate to tyrosine at codon six of the processed protein (Asp6Tyr) in the extracellular domain and was present in all affected family members but not in 100 unrelated controls. CONCLUSIONS: The present findings further extend the range of phenotypes associated with PMP0 mutations and indicate that families with "intermediate" HMSN need not necessarily be X-linked as previously suggested.
Authors: P H Meijerink; J E Hoogendijk; A A Gabreëls-Festen; I Zorn; H Veldman; F Baas; M de Visser; P A Bolhuis Journal: Ann Neurol Date: 1996-10 Impact factor: 10.422
Authors: L E Warner; M J Hilz; S H Appel; J M Killian; E H Kolodry; G Karpati; S Carpenter; G V Watters; C Wheeler; D Witt; A Bodell; E Nelis; C Van Broeckhoven; J R Lupski Journal: Neuron Date: 1996-09 Impact factor: 17.173
Authors: A A Gabreëls-Festen; J E Hoogendijk; P H Meijerink; F J Gabreëls; P A Bolhuis; S van Beersum; T Kulkens; E Nelis; F G Jennekens; M de Visser; B G van Engelen; C Van Broeckhoven; E C Mariman Journal: Neurology Date: 1996-09 Impact factor: 9.910
Authors: José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova Journal: J Neurol Date: 2017-03-31 Impact factor: 4.849
Authors: Florian P Thomas; Velina Guergueltcheva; Francisco A A Gondim; Ivailo Tournev; Chitharanjan V Rao; Boryana Ishpekova; Laurence J Kinsella; Yi Pan; Thomas J Geller; Ivan Litvinenko; Peter De Jonghe; Steven S Scherer; Albena Jordanova Journal: J Neurol Date: 2016-01-02 Impact factor: 4.849
Authors: Leah R Reznikov; Qian Dong; Jeng-Haur Chen; Thomas O Moninger; Jung Min Park; Yuzhou Zhang; Jianyang Du; Michael S Hildebrand; Richard J H Smith; Christoph O Randak; David A Stoltz; Michael J Welsh Journal: Proc Natl Acad Sci U S A Date: 2013-02-04 Impact factor: 11.205
Authors: Albena Jordanova; Florian P Thomas; Velina Guergueltcheva; Ivailo Tournev; Francisco A A Gondim; Borjana Ishpekova; Els De Vriendt; An Jacobs; Ivan Litvinenko; Neviana Ivanova; Borjan Buzhov; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman Journal: Am J Hum Genet Date: 2003-11-06 Impact factor: 11.025
Authors: L Santoro; F Manganelli; E Di Maria; D Bordo; D Cassandrini; F Ajmar; P Mandich; E Bellone Journal: J Neurol Neurosurg Psychiatry Date: 2004-02 Impact factor: 10.154